Global Automated Cell Imaging System Market Size & Trends

Global Automated Cell Imaging System Market Size & Trends

According to a new market research report published by Global Market Estimates, the Global Automated Cell Imaging System Market is projected to grow from USD 108.9 billion in 2022 to USD 200.7 billion in 2027 at a CAGR of 8.7% from 2022 to 2027.

The major drivers in the automated cell imaging system are its use in making drugs and medical processes for several life-threatening diseases such as cancer and tuberculous. An automated cell imaging system gives deep analysis for better results. These results are important in raising cases of cancer. Automated cell imaging uses the time-lapse microscopy method which helps monitor live cells over a period of time.

Browse 153 Market Data Tables and 113 Figures spread through 185 Pages and indepth TOC on “Global Automated Cell Imaging System Market - Forecast to 2027’’ https://www.globalmarketestimates.com/market-report/automated-cell-imaging-systemmarket-3841

By Methodology (Time Lapse, Colocalization), By Application (Live Cell Vivo Imaging, Screening), By End-Users (Hospitals, Diagnostic Laboratories), By Region (North America, Asia Pacific, Central & South America, Europe, and the Middle East & Africa), End-User Landscape Analysis, Company Market Share Analysis, and Competitor Analysis

Key Market Insights 

As per the methodology outlook, the time-lapse segment is expected to be the largest

 

segment in the automated cell imaging system market from 2022 to 2027 The Asia Pacific region is analyzed to be the fastest-growing segment in the market United States has the largest share in the market during the forecast period of 2022-



2027.

As per the application type, the live cell vivo imaging segment is expected to be the largest segment in the automated cell imaging system market from 2022 to 2027



Thermo Fisher Scientific, Spectral Instruments, PerkinElmer, Olympus, Nikon Instruments, Molecular Devices LLC, Logos Biosystems, Biotek Instruments, and GE Healthcare, are key players in the automated cell imaging system market.

Methodology Outlook (Revenue, USD Billion, 2022-2027)  

Time-Lapse Colocalization

Application Outlook (Revenue, USD Billion, 2022-2027)  

Live Cell Vivo Imaging Screening

End-Users Outlook (Revenue, USD Billion, 2022-2027)  

Hospital Diagnostic Laboratories

Regional Outlook (Revenue, USD Billion, 2022-2027) North America   

The U.S. Canada Mexico

Europe      

Germany UK France Spain Italy Rest of Europe

Asia Pacific     

China India Japan South Korea Australia



Rest of APAC

Central & South America   

Brazil Argentina Rest of CSA

Middle East & Africa   

Saudi Arabia UAE Rest of MEA

Contact: Yash Jain Email address: yash.jain@globalmarketestimates.com Phone Number: +1 6026667238